Posts by ericg
Second investigation into CCC chair hinges on treatment of executive director
A judge late last week cleared the way for Treasurer Deborah Goldberg to hold a hearing on the potential termination of Cannabis Control Commission Chair Shannon O’Brien, but the scheduling of that meeting is now tied to an open investigation that O’Brien thinks was "going well for her" when the treasurer’s team started downplaying its…
Read MoreTech layoffs 2023: Hundreds of job cuts continued to plague tech sector in Q4
In October, November and December, about ten tech companies headquartered or with signification operations in Massachusetts eliminated roughly 700 positions. Read More
Read MoreMeet the Boston innovation ecosystem leaders that emerged in 2023
Leadership changes shook up the ranks of organizations that support the local innovation ecosystem in 2023. Meet these new Boston tech leaders you need to know heading into 2024. Read More
Read MoreFive predictions for 2024’s real estate market
We close the book on 2023 with a look back at some of the year’s top stories in real estate, and we forecast what’s to come nationally in the year ahead. Read More
Read MoreMass. Clean Energy Center on verge of buying Salem port property
Coming soon to the state’s portfolio: 37-plus acres of harborside land in Salem, envisioned as the second major offshore wind port in Massachusetts. Read More
Read MoreFive things: Biotech layoffs, MGB mask mandate and feed your tree to a goat
Here are the five things you need to know, plus Visible Hands layoffs, Newbury Street rents and feed a goat your Christmas tree. Read More
Read MoreDespite headwinds, Newbury retail rents are higher than pre-Covid
Newbury Street may be tougher than critics have given it credit for. Neither the pandemic nor the emergence of high-end shops in the Seaport have hurt the street’s desirability among retailers and shoppers. Read More
Read MoreThese are the top tech stories of 2023 in Greater Boston
These are the top tech stories of 2023 in Greater Boston. Read More
Read MoreThe Petri Dish: Boston biotech scores FDA approval, antiviral maker stops 3 studies
Chiesi Global Rare Diseases, a Boston-based business unit of Italian biopharma firm Chiesi Group, scored an approval from the U.S. Food and Drug Administration for a skin disorder drug. Plus, other life sciences news you may have missed. Read More
Read MoreYear in Review: The biggest healthcare stories of 2023
From Dana-Farber’s split with MGB to the hack of Harvard Pilgrim, here are four of the biggest stories from the Boston-area healthcare sector in 2023. Read More
Read More